Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vicodin CR Long-Term Safety in Chronic Pain
NCT00195728Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of hydrocodone + acetaminophen in osteoarthritis (OA) and low back pain (LBP), sponsored by Abbott Laboratories. Primary endpoint: Safety evaluation at 56 weeks. Started Jun 2005; status: completed.
02
Drugs
hydrocodone + acetaminophen
03
Conditions
osteoarthritis (OA)low back pain (LBP)
Beyond the preview
Go deeper on NCT00195728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195728.